The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
The Microbiota Makes for Good Therapy: The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967 ) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et al. (p. 971 ) found a similar effect of the microbiota on tumor-bearing mice treated with cyclophosphamide, but in this case it appeared that the microbiota promoted an adaptive immune response against the tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and that therapeutic responses may be improved via its modulation (13, 14)”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [14]
In the citing paper
“The P-ESC was considered representative of baseline microbiome data due to observations that the microbiome of patients treated with anti-PD-1, unlike anti-CTLA-4 or chemotherapy, is stable early after therapy initiation17–19.”
From Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 (2022) · cites this paper as [19]
In the citing paper
“In mouse models, certain gut commensals mediate efficacy of anticancer therapies, including chemotherapy, radiotherapy, and immunotherapies such as adoptive T cell transfer, intratumoral CpG-oligonucleotides, and ICIs.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [3]
In the citing paper
“In addition, broad-spectrum antibiotics (mainly beta-lactams) taken prior to immunotherapy markedly reduce the clinical benefit of ICIs, chimeric antigen receptor (CAR)-T cells, stem cell transplantation in patients, and immunogenic chemotherapy in preclinical tumor models.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [3]
In the citing paper
“The gut microbiome has been shown to have multiple effects on tumor biology, such as the transformation process, tumor progression, and the response to anticancer therapies including immunotherapy (21-29).”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [26]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Finally, monoassociation of tumor-bearing GF mice with SFB, which promotes Th17 cell differentiation in the LP (1, 13, 14) also had a detrimental impact on the tumor growthinhibitory effect of CTX (Fig.”
BackgroundImmunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303 · cited 1×
“Some antineoplastic agents mediate part of their anticancer activity by stimulating anticancer immune responses (6).”
BackgroundSelf-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“S6A) and is required for the therapeutic success of anticancer chemotherapies in several tumor models (19).”
BackgroundSelf-citationInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Self-citation
Research works printed but not linked: 1
- 10.1073/pnas.1113744109 · DOI · Paper page
Cited by
Items 901–1,000 of 1,012
The human microbiome and genitourinary malignancies
Nicolaro, M., Portal, D. E., Shinder, B. M., Patel, H. V., & Singer, E. A. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2976 · Cited by 31
The Microbiome and Its Implications in Cancer Immunotherapy
Choudhry, H. (2021) · Molecules · doi:10.3390/molecules26010206 · Cited by 31
Yu, Q., Jobin, C., & Thomas, R. M. (2021) · Neoplasia · doi:10.1016/j.neo.2020.12.008 · Cited by 33
Fan, S., Zhang, Z.-H., Zhong, Y.-D., Li, C., Huang, X.-J., Geng, F., & Nie, S.-P. (2021) · Food & Function · doi:10.1039/d1fo00410g · Cited by 28
Prevotella contributes to individual response of FOLFOX in colon cancer
Hou, X., Zhang, P., Du, H., Gao, Y., Sun, R., Qin, S., Tian, Y., Li, J., Zhang, Y., Chu, W., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.512 · Cited by 31
The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer
Yu, I., Wu, R., Tokumaru, Y., Terracina, K. P., & Takabe, K. (2022) · Cancers · doi:10.3390/cancers14225685 · Cited by 34
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients
Grenda, A., Iwan, E., Krawczyk, P. A., Frąk, M., Chmielewska, I., Bomba, A., Giza, A., Rolska-Kopińska, A., Szczyrek, M., Kieszko, R., et al. (2022) · Cancers · doi:10.3390/cancers14246250 · Cited by 31
Huang, J., Gong, C., & Zhou, A. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231204854 · Cited by 33
Anti-PD1 in the wonder-gut-land
Vétizou, M., & Trinchieri, G. (2018) · Cell Research · doi:10.1038/cr.2018.12 · Cited by 31
Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers
Zhang, X., & Pan, Z. (2020) · Gastroenterology report · doi:10.1093/gastro/goaa014 · Cited by 32
Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity
Baiden-Amissah, R. E. M., & Tuyaerts, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143586 · Cited by 30
The role of microbiomes in gastrointestinal cancers: new insights
Yarahmadi, A., & Afkhami, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1344328 · Cited by 30
Oncometabolites in cancer: from cancer cells to the tumor microenvironment
Chen, L., & Huang, M. (2024) · Holistic Integrative Oncology · doi:10.1007/s44178-024-00096-7 · Cited by 33
Does the microbiome play a causal role in spondyloarthritis?
Rosenbaum, J. T., Lin, P., Asquith, M. J., Costello, M., Kenna, T., & Brown, M. A. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2664-5 · Cited by 35
Common TLR5 Mutations Control Cancer Progression
Pfirschke, C., Garris, C., & Pittet, M. J. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.008 · Cited by 30
Self-citationBruneau, A., Baylatry, M., Joly, A. C., & Sokol, H. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.10.025 · Cited by 35
Living Therapeutics: The Next Frontier of Precision Medicine
Kelly, V. W., Liang, B. K., & Sirk, S. J. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00444 · Cited by 30
Dong, J., Gao, H.-L., Wang, W., Yu, X., & Liu, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188484 · Cited by 31
Ding, Z., Aboelella, N. S., Bryan, L. J., Shi, H., & Zhou, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594540 · Cited by 37
Liu, Y., Li, X., Li, J., & Chen, W. (2021) · Ecology and Evolution · doi:10.1002/ece3.7407 · Cited by 35
The Role of the Microbiome in Liver Cancer
Moreno‐Gonzalez, M., & Beraza, N. (2021) · Cancers · doi:10.3390/cancers13102330 · Cited by 35
Youssef, M., Ahmed, H. Y., Zongo, A. W., Korin, A., Zhan, F., Hady, E., Umair, M., Rajoka, M. S. R., Xiong, Y., & Li, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011290 · Cited by 32
Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy
Bae, J., Park, K., & Kim, Y. (2022) · Immune Network · doi:10.4110/in.2022.22.e3 · Cited by 32
Brevi, A., Cogrossi, L. L., Lorenzoni, M., Mattorre, B., & Bellone, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845422 · Cited by 32
D'Angelo, C. R., Sudakaran, S., Asimakopoulos, F. A., Hematti, P., El‐Gamal, D., Safdar, N., & Callander, N. S. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2131410 · Cited by 30
Hong, X., Yu, T., Huang, X., Wang, J., Sun, T., Yan, T., Zhou, C., Chen, H., Su, W., Du, W., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02044-6 · Cited by 31
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma
Tripodi, L., Feola, S., Granata, I., Whalley, T., Passariello, M., Capasso, C., Coluccino, L., Vitale, M., Scalia, G., Gentile, L., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107668 · Cited by 31
Microbiome in Cancer Development and Treatment
Čierniková, S., Ševčíková, A., Mladosievičová, B., & Mego, M. (2023) · Microorganisms · doi:10.3390/microorganisms12010024 · Cited by 32
Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments
Faïs, T., Delmas, J., Cougnoux, A., Dalmasso, G., & Bonnet, R. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1155020 · Cited by 34
Progress and challenges for treating Type 1 diabetes
Garyu, J., Meffre, E., Cotsapas, C. J., & Herold, K. C. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.04.004 · Cited by 32
Zhu, X.-H., Lang, H., Wang, X., Hui, S., Zhou, M., Kang, C., Yi, L., Mi, M., & Zhang, Y. (2019) · Food & Function · doi:10.1039/c8fo01756e · Cited by 30
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Araujo, D. V., Watson, G. A., Oliva, M., Heirali, A., Coburn, B., Spreafico, A., & Siu, L. L. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102125 · Cited by 29
Wekking, D., Silva, C. A. C., Viscò, R., Denaro, N., Lambertini, M., Maccioni, A., Loddo, E., Willard-Gallo, K. E., Scartozzi, M., Derosa, L., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104767 · Cited by 30
Wang, L., Jiang, W., Yang, M., Danzeng, Q., Liu, S., & Cui, M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02275-z · Cited by 29
Chen, L., Tai, W., Brar, M. S., Leung, F. C.-C., & Hsiao, W. L. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126807 · Cited by 29
Bhushan, B., Singh, B. P., Saini, K., Kumari, M., Tomar, S. K., & Mishra, V. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-019-00914-9 · Cited by 29
Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy
Anfossi, S., & Călin, G. A. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.04 · Cited by 35
Wang, L., Peng, F., Peng, C. Y., & Du, J. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500270 · Cited by 30
Yu, M., Li, L., Ren, Q., Feng, H., Tao, S., Cheng, L., Ma, L., Gou, S., & Fu, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.783679 · Cited by 29
Sampsell, K., Wang, W., Ohland, C., Mager, L. F., Pett, N., Lowry, D. E., Sales, K. M., McNeely, M. L., McCoy, K. D., Culos-Reed, S. N., et al. (2022) · Cancers · doi:10.3390/cancers14112722 · Cited by 30
The microbiota and radiotherapy for head and neck cancer: What should clinical oncologists know?
Ferreira, M. R., Pastò, A., Ng, T., Patel, V., Urbano, T. G., Sears, C. L., & Wade, W. G. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102442 · Cited by 29
Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation
Tchitchek, N., Tchoumba, O. F. N., Pires, G., Dandou, S., Campagne, J., Churlaud, G., Fourcade, G., Hoffmann, T. W., Strozzi, F., Gaal, C., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159406 · Cited by 29
Yang, S., Zhao, S., Ye, Y., Jia, L., & Lou, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952546 · Cited by 33
Kim, S., Kim, Y., Lee, S., Kim, Y., Jeon, B., Kim, H., & Park, H. (2022) · Cancers · doi:10.3390/cancers14174083 · Cited by 30
The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy
Qi, X., Liu, Y., Hussein, S., Choi, G., Kimchi, E. T., Staveley-O’Carroll, K. F., & Li, G. (2022) · Cells · doi:10.3390/cells11223684 · Cited by 30
Zhou, B., Dong, C., Zhao, B., Lin, K., Tian, Y., Zhang, R., Zhu, L., Xu, H., & Yang, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1015130 · Cited by 29
Natural Useful Therapeutic Products from Microbes
Gupta, C. (2014) · Journal of Microbiology & Experimentation · doi:10.15406/jmen.2014.01.00006 · Cited by 29
Heine, A., Flores, C., Gevensleben, H., Diehl, L., Heikenwälder, M. F., Ringelhan, M., Janssen, K., Nitsche, U., Garbi, N., Brossart, P., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1338995 · Cited by 29
Microbiota control immune regulation in humanized mice
Gülden, E., Vudattu, N. K., Deng, S., Preston‐Hurlburt, P., Mamula, M. J., Reed, J. C., Mohandas, S., Herold, B. C., TORRES, R. A., Vieira, S. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91709 · Cited by 30
More than a leaky gut: how gut priming shapes arthritis
Kuhn, K. A., Yomogida, K., Knoop, K. A., Wu, H.-J. J., & Zaiss, M. M. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01282-1 · Cited by 30
Tini, S., Baima, J., Pigni, S., Antoniotti, V., Caputo, M., Palma, E. D., Cerbone, L., Grosso, F., Vecchia, M. L., Bona, E., et al. (2025) · Nutrients · doi:10.3390/nu17172898 · Cited by 30
Gut microbiota sustains hematopoiesis
Theilgaard‐Mönch, K. (2017) · Blood · doi:10.1182/blood-2016-12-754481 · Cited by 28
Gut Microbiota and Immune Responses
Dong, L., Xie, J., Wang, Y., & Zuo, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_10 · Cited by 31
Salehi, B., Dimitrijević, M., Aleksić, A., Neffe‐Skocińska, K., Zielińska, D., Kołożyn‐Krajewska, D., Sharifi‐Rad, J., Stojanović-Radić, Z. Z., Prabu, S. M., Rodrigues, C. F., et al. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1760202 · Cited by 34
RetractedStrategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy
Moaven, O., Mangieri, C. W., Stauffer, J. A., Anastasiadis, P. Z., & Borad, M. J. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00003 · Cited by 32
Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies
Rinninella, E., Raoul, P. C., Cintoni, M., Palombaro, M., Pulcini, G., Gasbarrini, A., & Mele, M. C. (2021) · Microorganisms · doi:10.3390/microorganisms9071469 · Cited by 28
Bredin, P., & Naidoo, J. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10039-1 · Cited by 29
Deng, Y., Zhao, L., Huang, X., Zeng, Y., Xiong, Z., & Zuo, M. (2022) · Nutrition · doi:10.1016/j.nut.2022.111829 · Cited by 31
The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host
Huang, J., & Mao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1029033 · Cited by 28
Intratumor microbiota: a novel tumor component
Gong, Y., Huang, X., Wang, M., & Liang, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04576-7 · Cited by 28
Complex interactions of cellular players in chronic Graft-versus-Host Disease
Gail, L. M., Schell, K. J., Łacina, P., Strobl, J., Bolton, S. J., Ulriksen, E. S., Bogunia‐Kubik, K., Greinix, H., Crossland, R. E., Inngjerdingen, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199422 · Cited by 29
Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer
Xu, Y., Du, H., Chen, Y., Ma, C., Zhang, Q., Li, H., Xie, Z., & Hong, Y. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2233605 · Cited by 28
Voorde, J. V., Vervaeke, P., Liekens, S., & Balzarini, J. M. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.07.007 · Cited by 28
Effects of ceftriaxone induced intestinal dysbacteriosis on lymphocytes in different tissues in mice
Luo, X., Zheng, Y., Wen, R., Deng, X., Zhou, L., & Liao, H. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.04.003 · Cited by 28
The Mycobiome: Impact on Health and Disease States
El‐Jurdi, N., & Ghannoum, M. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0045-2016 · Cited by 30
The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors
Alkharabsheh, O. A., Sidiqi, M. H., Aljama, M. A., Gertz, M. A., & Frankel, A. E. (2019) · Acta Haematologica · doi:10.1159/000500976 · Cited by 28
Zhang, H., Hui, D., Li, Y., Xiong, G., & Fu, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01149 · Cited by 27
He, Z., Xie, H., Xu, H., Wu, J., Zeng, W., He, Q., Jobin, C., Jin, S., & Lan, P. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2319511 · Cited by 27
Constantin, M., Chifiriuc, M. C., Mihăescu, G., Corcionivoschi, N., Burlibaşa, L., Bleoţu, C., Tudorache, S. I., Mitache, M. M., Filip, R., Munteanu, S.-G., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1373504 · Cited by 27
New insights into gut microbiota–prostate cancer crosstalk
Laaraj, J., Lachance, G., Bergeron, A., Fradet, Y., Robitaille, K., & Fradet, V. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.03.015 · Cited by 27
Ducasse, H., Arnal, A., Vittecoq, M., Daoust, S. P., Újvári, B., Jacqueline, C. M., Tissot, T., Ewald, P. W., Gatenby, R. A., King, K. C., et al. (2015) · Evolutionary Applications · doi:10.1111/eva.12232 · Cited by 29
Goc, J., Hepworth, M. R., & Sonnenberg, G. F. (2015) · International Immunology · doi:10.1093/intimm/dxv056 · Cited by 29
The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy
Kim, J.-H., & Lee, H. K. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0032 · Cited by 29
Gut Microbiota: A Potential Target for Cancer Interventions
Zhou, H., Yuan, Y., Wang, H., Xiang, W., Li, S., Zheng, H., Wen, Y., Yang, M., Chen, L., & Zhou, J. (2021) · Cancer Management and Research · doi:10.2147/cmar.s328249 · Cited by 30
Gut Microbes in Gynecologic Cancers: Causes or Biomarkers and Therapeutic Potential
Han, M., Wang, N., Han, W., Ban, M., Sun, T., & Xu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.902695 · Cited by 28
Dacrema, M., Ali, A., Ullah, H., Khan, A., Minno, A. D., Xiao, J., Martins, A. M. C., & Daglia, M. (2022) · Cancers · doi:10.3390/cancers14225682 · Cited by 31
Knisely, A. T., Seo, Y. D., Wargo, J. A., & Chelvanambi, M. (2023) · Cancers · doi:10.3390/cancers15030777 · Cited by 32
The human microbiome: A promising target for lung cancer treatment
Sun, Y. H., Wen, M., Liu, Y., Wang, Y., Jing, P., Gu, Z., Jiang, T., & Wang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1091165 · Cited by 30
Li, T., Han, L., Ma, S., Lin, W., Ba, X. W., Yan, J., Huang, Y., Tu, S., & Qin, K. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1140325 · Cited by 29
Increased Intestinal Permeability: An Avenue for the Development of Autoimmune Disease?
English, J., Connolly, L., & Stewart, L. D. (2023) · Exposure and Health · doi:10.1007/s12403-023-00578-5 · Cited by 28
Zhu, X., Zhang, X., Shen, J., Zheng, S., Li, H., Han, B., Zhang, C., Chen, M., Sun, Q., & Wu, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155413 · Cited by 27
Xu, C., Ruan, B., Jiang, Y., Xue, T., Wang, Z., Lu, H., Wei, M., Wang, S., Ye, Z., Zhai, D., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.071 · Cited by 27
Adaptation of Candida albicans During Gastrointestinal Tract Colonization
Mishra, A. A., & Koh, A. Y. (2018) · Current Clinical Microbiology Reports · doi:10.1007/s40588-018-0096-8 · Cited by 26
Discovery of an interplay between the gut microbiota and esophageal squamous cell carcinoma in mice.
Cheung, M. K., Yue, G. G., Tsui, K.-Y., Gomes, A. J., Kwan, H. S., Chiu, P. W. Y., & Lau, C. B. (2020) · PubMed · Cited by 28
Antibiotics, cancer risk and oncologic treatment efficacy: a practical review of the literature
Lopes, M. S. M., Machado, L. M., Silva, P. A. I. A., Uchiyama, A. A. T., Yen, C. T., Ricardo, E. D., Mutão, T. S., Pimento, J. R., Shimba, D. S., Hanriot, R. D. M., et al. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1106 · Cited by 29
“Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities”
Delahousse, J., Molina, L., & Paci, A. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217119 · Cited by 29
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma
Yao, J., Ning, B., & Ding, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2473504 · Cited by 28
Dumitru, I. G., Todor, S. B., Ichim, C., Helgiu, C., & Helgiu, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092982 · Cited by 27
Chattopadhyay, I., Nandi, D., & Nag, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.012 · Cited by 27
Microbiome-based interventions: therapeutic strategies in cancer immunotherapy
Chervin, C. S., & Gajewski, T. F. (2020) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2020.11.001 · Cited by 29
Koulouridi, A., Messaritakis, I., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2020) · Cancers · doi:10.3390/cancers13010043 · Cited by 27
Antimicrobial therapy during cancer treatment: Beyond antibacterial effects
Ghanem, S., Kim, C. J., Dutta, D., Salifu, M. O., & Lim, S. H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13238 · Cited by 27
Lione, L., Salvatori, E., Petrazzuolo, A., Massacci, A., Maggio, R., Conforti, A., Compagnone, M., Aurisicchio, L., Ciliberto, G., & Palombo, F. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1898832 · Cited by 27
Immune Checkpoint Inhibitors: Review of the Existing Evidence and Challenges in Breast Cancer
Jalalvand, M., Darbeheshti, F., & Rezaei, N. (2021) · Immunotherapy · doi:10.2217/imt-2020-0283 · Cited by 26
Implication of gut microbes and its metabolites in colorectal cancer
Kumar, A., Ali, A., Kapardar, R. K., Dar, G. M., Nimisha, Apurva, A., Sharma, A. K., Verma, R., Sattar, R. S. A., Ahmad, E., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04422-2 · Cited by 26
Zhao, Z.-W., Sun, M., Cui, X., Chen, J.-X., Liu, C., & Zhang, X.-W. (2023) · Scientific Reports · doi:10.1038/s41598-023-38379-0 · Cited by 23
Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
Gong, Y., Liu, Z., Zhou, P., Li, J., & Miao, Y. (2023) · Nano TransMed · doi:10.1016/j.ntm.2023.100020 · Cited by 27
The microbiome and gynecologic cancer: cellular mechanisms and clinical applications
Chalif, J., Wang, H., Spakowicz, D. J., Quick, A. M., Arthur, E. K., O’Malley, D. M., & Chambers, L. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2023-004894 · Cited by 28
Nelson, M. H., Bowers, J. S., Bailey, S. R., Diven, M. A., Fugle, C. W., Kaiser, A., Wrzesinski, C., Liu, B., Restifo, N. P., & Paulos, C. M. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0110-8 · Cited by 27
The Microbiota: A New Variable Impacting Cancer Treatment Outcomes
Fessler, J. L., & Gajewski, T. F. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0864 · Cited by 24
Metadata
- Authors
- Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., Schlitzer, A., Ginhoux, F., Apetoh, L., Chachaty, E., Woerther, P.-L., Eberl, G., Bérard, M., Ecobichon, C., Clermont, D., Bizet, C., Gaboriau-Routhiau, V., Cerf-Bensussan, N., Opolon, P., Yessaad, N., Vivier, E., Ryffel, B., Elson, C. O., Doré, J., Kroemer, G., Lepage, P., Boneca, I. G., Ghiringhelli, F., & Zitvogel, L.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Harvard University (US)
- Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Agency for Science, Technology and Research (SG)
- Institut National de la Santé et de la Recherche Médicale, U866, Centre Georges François Leclerc, Dijon, France.
- Service de Microbiologie, Institut Gustave Roussy, Villejuif, France.
- Institut Gustave Roussy (FR)
- Institut Pasteur (FR)
- Nimalerie Centrale, Institut Pasteur, Paris, France.
- Institut National de la Recherche Agronomique, Micalis–UMR1319, 78350 Jouy-en-Josas, France.
- Centre National de la Recherche Scientifique (FR)
- Centre d’Immunologie de Marseille-Luminy, Aix-Marseille Université UM2, Marseille, France.
- Université d'Orléans (FR)
- University of Alabama at Birmingham (US)
- AgroParisTech (FR)
- Corresponding author
- Ghiringhelli, François
- Zitvogel, Laurence
- ORCID
- Mignot, Grégoire
- Yamazaki, Takahiro
- Daillère, Romain
- Hannani, Dalil
- Pfirschke, Christina
- Engblom, Camilla
- Schlitzer, Andreas
- Ginhoux, Florent
- Woerther, Paul-Louis
- Eberl, Gérard
- Clermont, Dominique
- Opolon, Paule
- Ryffel, Bernhard
- Elson, Charles O.
- Kroemer, Guido
- Lepage, Patricia
- Boneca, Ivo Gomperts
- Ghiringhelli, François
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2013-11-22
- Volume
- 342
- Issue
- 6161
- Pages
- 971-976
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4048947
- OpenAlex
- W2059128083
- Cited by
- 2,050
- References
- 43
- Citations by year
- 2026: 109 · 2025: 165 · 2024: 176 · 2023: 216 · 2022: 234 · 2021: 217 · 2020: 220 · 2019: 183 · 2018: 137 · 2017: 116 · 2016: 98 · 2015: 101 · 2014: 69 · 2013: 6
- FWCI
- 40.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- HAL AMU (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-11-PHUC-0002)
- National Cancer Institute (P50CA086355)
- National Institute of Allergy and Infectious Diseases (R01AI084880)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK071176)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- cyclophosphamide, gut microbiota, antitumor immunity, Gram-positive bacteria, Th17 cells, memory T cells, secondary lymphoid organs, bacterial translocation, germ-free mice, antibiotic therapy, adoptive transfer, small intestine
- MeSH terms
- Animals, Anti-Bacterial Agents, Antineoplastic Agents, Cyclophosphamide, Germ-Free Life, Gram-Positive Bacteria, Immunologic Memory, Immunosuppressive Agents, Intestine, Small, Lymphoid Tissue, Neoplasms, Bacterial Translocation, Adoptive Transfer, Mice, Th17 Cells, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.